NATIONAL BUREAU OF ECONOMIC RESEARCH
NATIONAL BUREAU OF ECONOMIC RESEARCH

Cost-Sharing and Productivity

Teresa B. Gibson, A. Mark Fendrick, Michael E. Chernew

NBER Working Paper No. 18402
Issued in September 2012

---- Acknowledgements -----

Funding for this study was provided by Pfizer Inc. to Truven Health Analytics (formerly Thomson Reuters Healthcare). All opinions expressed are those of the authors. We thank Amanda Farr, MPH for research and programming assistance. The views expressed herein are those of the authors and do not necessarily reflect the views of the National Bureau of Economic Research.

---- Disclosure of Financial Relationships for Teresa B. Gibson -----

Teresa B. Gibson is a salaried employee of Truven Health Analytics, a health care consulting firm that performs contract research. In this capacity she has performed studies funded by BMS, Merck, Pfizer and the National Pharmaceutical Council.

---- Disclosure of Financial Relationships for Michael E. Chernew -----

Consultant: Abbott, AonHewitt, AstraZeneca, Aventis Pharmaceuticals, Blue Shield of California, Bristol-Myers Squibb, Center for Medicare and Medicaid Services [CMS], Genentech, GlaxoSmithKline, Health Alliance Plan, Highmark BlueCross BlueShield, Merck and Co., National Business Coalition on Health, National Pharmaceutical Council, Neocure Group LLC, Pennsylvania State Trooper’s Association, Pfizer Inc., POZEN, Inc., Precision Health Economics LLC, Thomson Reuters, TriZetto, zanzors

Speaker’s Bureau: Merck and Co., Pfizer Inc.

Research: Abbott, AstraZeneca, Aventis Pharmaceuticals, Eli Lilly, Genentech, GlaxoSmithKline, Merck and Co., Novartis, Pfizer Inc.

return to bibliography page

 
Publications
Activities
Meetings
NBER Videos
Data
People
About

Support
National Bureau of Economic Research, 1050 Massachusetts Ave., Cambridge, MA 02138; 617-868-3900; email: info@nber.org

Contact Us